BFNH (BioForce Nanosciences Holdings) 5-Year EBITDA Growth Rate: 60.40% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BFNH BioForce Nanosciences Holdings Inc BFNH
32 GF Score
Price $2.70
! 1 Warning Sign
View Full Analysis

What is BioForce Nanosciences Holdings 5-Year EBITDA Growth Rate?

BioForce Nanosciences Holdings BFNH +4.65% 32 5-Year EBITDA Growth Rate is 60.40% as of Jun. 2026. GuruFocus rates BFNH with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

BioForce Nanosciences Holdings's EBITDA per Share for the three months ended in Jun. 2026 was $-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 4.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 60.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioForce Nanosciences Holdings was 89.00% per year. The lowest was -1593.60% per year. And the median was 0.00% per year.

BioForce Nanosciences Holdings  (OTCPK:BFNH) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

BioForce Nanosciences Holdings 5-Year EBITDA Growth Rate Related Terms

BFNH vs BHST, LSF, HAIN: 5-Year EBITDA Growth Rate Comparison

For the Packaged Foods subindustry, BioForce Nanosciences Holdings's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioForce Nanosciences Holdings 5-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, BioForce Nanosciences Holdings's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where BioForce Nanosciences Holdings's 5-Year EBITDA Growth Rate falls into.


BFNH
32GF Score
BioForce Nanosciences Holdings Inc BFNH
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioForce Nanosciences Holdings 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 60.40% mean?
BioForce Nanosciences Holdings (BFNH) has a 5-Year EBITDA Growth Rate of 60.40% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for BioForce Nanosciences Holdings and its competitors.
Is BioForce Nanosciences Holdings' 5-Year EBITDA Growth Rate too high?
BioForce Nanosciences Holdings' current 5-Year EBITDA Growth Rate is 60.40%. Overall, BioForce Nanosciences Holdings has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does BioForce Nanosciences Holdings' 5-Year EBITDA Growth Rate compare to BHST and LSF?
BioForce Nanosciences Holdings' 5-Year EBITDA Growth Rate of 60.40% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
A good 5-Year EBITDA Growth Rate depends on the Consumer Packaged Goods industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for BioForce Nanosciences Holdings and its competitors. BioForce Nanosciences Holdings's current 5-Year EBITDA Growth Rate is 60.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioForce Nanosciences Holdings stock overvalued right now?
BioForce Nanosciences Holdings (BFNH) has a current 5-Year EBITDA Growth Rate of 60.40%. The current 5-Year EBITDA Growth Rate is 60.40%. BioForce Nanosciences Holdings' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For BioForce Nanosciences Holdings (BFNH), the current 5-Year EBITDA Growth Rate is 60.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioForce Nanosciences Holdings Business Description

Address 2020 General Booth Boulevard, Suite 230, Virginia Beach, VA, USA, 23454
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
32GF Score

Get the complete analysis for BFNH

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.70
Price